The U.S. Dept. of Defense awarded PerkinElmer Genetics a 16-month contract for newborn screening and supplies.
The deal is worth up to $9.7 million for the Bridgeville, Pa.-based PerkinElmer Inc. (NYSE:PKI) unit.
The Defense Dept. selected the company from a total of three bidders and the contract runs through May 6, 2012. The branches of the military using the service will be the Army, Navy, Air Force and Marine Corps, according the DoD.
PerkinElmer Genetics, which Waltham, Mass.-based PerkinElmer acquired from Pediatrix Medical Group Inc. in Feb. 2008, makes a newborn screening product called StepOne that is "capable of analyzing more than 50 inherited disorders in newborns," according to the company’s website.